Typical treatment for<unk>  includes conservative use of corticosteroids such as a short course of oral prednisone or methylprednisolone. Inhaled corticosteroids such as fluticasone or budesonide may also be effective for reducing inflammation and preventing re-inflammation on a chronic level by suppressing inflammatory processes that may be triggered by environmental exposures such as allergens. Severe cases of<unk>  may require corticosteroids and oxygen therapy, as well as elimination of exposure to known irritants. Corticosteroid dose and treatment duration vary from case to case. However, a common regimen beginning at 0.5 mg/kg per day for a couple of days before tapering to a smaller dose for several months to a year, has been used successfully. Corticosteroids effectively reduce inflammation by switching off several genes activated during an inflammatory reaction. The production of anti-inflammatory proteins, and the degeneration of mRNA encoding inflammatory proteins, can also be increased by a high concentration of corticosteroids. These responses can help mitigate the inflammation seen in<unk>  and reduce symptoms. Certain immune-modulating treatments may be appropriate for patients suffering from chronic<unk> . Azathioprine and mycophenolate are two particular treatments that have been associated with an improvement of gas exchange. Patients with chronic<unk>  also may be evaluated for lung transplantation.
Pneumonitis
Bronchitis
Pneumonia
Croup
Hydrothorax
Bronchopneumonia
Bronchorrhea
Tracheitis